Zeidan, A M <br/><br/>
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides.  [electronic resource] 

 -  Leukemia  Mar 2016 
 - 649-57 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2015.283  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Azacitidine--analogs & derivatives<br/>Databases, Factual<br/>Decitabine<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--diagnosis<br/>Prognosis<br/>Research Design<br/>Risk Factors<br/>Survival Analysis